Invex Therapeutics Ltd (IXC.AX)
AUD 0.07
(-10.67%)
AUD 0.07
(-10.67%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -720.44 Thousand AUD | 0.0% |
| 2023 | - AUD | -111.69% |
| 2022 | - AUD | -73.65% |
| 2021 | - AUD | 25.76% |
| 2020 | - AUD | -944.77% |
| 2019 | - AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | 62.76% |
| 2024 Q2 | 376.64 Thousand AUD | 0.0% |
| 2024 Q4 | -856.54 Thousand AUD | 0.0% |
| 2023 Q3 | 1112.00 AUD | 100.02% |
| 2023 FY | - AUD | -111.69% |
| 2023 Q4 | -4.36 Million AUD | -392463.31% |
| 2023 Q2 | -4.64 Million AUD | -1268.24% |
| 2023 Q1 | 397.43 Thousand AUD | 118.09% |
| 2022 Q2 | -2.01 Million AUD | -1913.87% |
| 2022 Q1 | 111.27 Thousand AUD | 108.75% |
| 2022 FY | - AUD | -73.65% |
| 2022 Q4 | -2.19 Million AUD | -2979.54% |
| 2022 Q3 | -71.33 Thousand AUD | 96.47% |
| 2021 FY | - AUD | 25.76% |
| 2021 Q1 | -840.06 Thousand AUD | 61.91% |
| 2021 Q4 | -1.27 Million AUD | -5851.42% |
| 2021 Q3 | 22.11 Thousand AUD | 101.89% |
| 2021 Q2 | -1.17 Million AUD | -39.35% |
| 2020 FY | - AUD | -944.77% |
| 2020 Q4 | -2.2 Million AUD | -162.54% |
| 2020 Q3 | -840.06 Thousand AUD | 30.14% |
| 2020 Q2 | -1.2 Million AUD | -2717.83% |
| 2020 Q1 | 45.93 Thousand AUD | 0.0% |
| 2019 Q3 | - AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 106.944% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 50.542% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 98.023% |
| Biome Australia Limited | -1.57 Million AUD | 54.352% |
| Patrys Limited | -3.49 Million AUD | 79.37% |
| Orthocell Limited | -11.68 Million AUD | 93.832% |
| Imugene Limited | -147.97 Million AUD | 99.513% |
| Noxopharm Limited | -5.94 Million AUD | 87.883% |
| PYC Therapeutics Limited | -38.11 Million AUD | 98.11% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | 93.624% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 89.974% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | 90.866% |
| Cynata Therapeutics Limited | -9.95 Million AUD | 92.76% |
| CSL Limited | 4.73 Billion AUD | 100.015% |
| Arovella Therapeutics Limited | -8.83 Million AUD | 91.844% |
| Bio-Gene Technology Limited | -2.97 Million AUD | 75.783% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 101.389% |
| Starpharma Holdings Limited | -12.57 Million AUD | 94.272% |
| Nanollose Limited | -1.14 Million AUD | 37.238% |
| Memphasys Limited | -3.3 Million AUD | 78.219% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | 59.893% |
| Amplia Therapeutics Limited | -4.55 Million AUD | 84.199% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | 94.824% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | 74.435% |
| Race Oncology Limited | -14.2 Million AUD | 94.928% |
| Nyrada Inc. | -4.59 Million AUD | 84.325% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 103.137% |
| Dimerix Limited | -24.95 Million AUD | 97.113% |
| PharmAust Limited | -9.45 Million AUD | 92.378% |
| Immutep Limited | -42.87 Million AUD | 98.32% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 98.386% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 96.319% |
| BTC Health Limited | 1.05 Million AUD | 168.27% |
| Acrux Limited | -7.93 Million AUD | 90.916% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 100.362% |
| Biotron Limited | -5.04 Million AUD | 85.706% |
| Tissue Repair Ltd | -5.77 Million AUD | 87.525% |
| AdAlta Limited | -5.3 Million AUD | 86.414% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 98.412% |
| Hexima Limited | -995.54 Thousand AUD | 27.633% |
| AnteoTech Limited | -11.57 Million AUD | 93.774% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 98.884% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 96.626% |
| Avecho Biotechnology Limited | -3.24 Million AUD | 77.781% |
| Actinogen Medical Limited | -12.92 Million AUD | 94.424% |
| Immuron Limited | -6.19 Million AUD | 88.366% |
| Argenica Therapeutics Limited | -1.89 Million AUD | 62.034% |